Organon & Co. (FRA:7XP)
6.79
+0.43 (6.72%)
At close: Feb 20, 2026
Organon & Co. Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 6,216 | 6,403 | 6,263 | 6,174 | 6,304 |
Revenue Growth (YoY) | -2.92% | 2.23% | 1.44% | -2.06% | -3.49% |
Cost of Revenue | 2,854 | 2,688 | 2,515 | 2,289 | 2,375 |
Gross Profit | 3,362 | 3,715 | 3,748 | 3,885 | 3,929 |
Selling, General & Admin | 1,711 | 1,758 | 1,811 | 1,702 | 1,669 |
Research & Development | 366 | 469 | 528 | 471 | 339 |
Operating Expenses | 2,077 | 2,227 | 2,339 | 2,173 | 2,008 |
Operating Income | 1,285 | 1,488 | 1,409 | 1,712 | 1,921 |
Interest Expense | -504 | -520 | -527 | -422 | -258 |
Currency Exchange Gain (Loss) | -14 | -26 | -42 | -11 | -4 |
Other Non Operating Income (Expenses) | 119 | -12 | -17 | -17 | -16 |
EBT Excluding Unusual Items | 886 | 930 | 823 | 1,262 | 1,643 |
Merger & Restructuring Charges | -154 | -31 | -62 | -28 | -3 |
Impairment of Goodwill | -301 | - | - | - | - |
Asset Writedown | - | - | - | - | -7 |
Legal Settlements | - | - | -80 | - | - |
Other Unusual Items | - | -11 | - | -5 | - |
Pretax Income | 425 | 807 | 673 | 1,122 | 1,529 |
Income Tax Expense | 238 | -57 | -350 | 205 | 178 |
Earnings From Continuing Operations | 187 | 864 | 1,023 | 917 | 1,351 |
Net Income | 187 | 864 | 1,023 | 917 | 1,351 |
Net Income to Common | 187 | 864 | 1,023 | 917 | 1,351 |
Net Income Growth | -78.36% | -15.54% | 11.56% | -32.12% | -37.45% |
Shares Outstanding (Basic) | 259 | 257 | 255 | 254 | 254 |
Shares Outstanding (Diluted) | 261 | 259 | 256 | 255 | 254 |
Shares Change (YoY) | 0.62% | 1.13% | 0.43% | 0.38% | 0.27% |
EPS (Basic) | 0.72 | 3.36 | 4.01 | 3.61 | 5.33 |
EPS (Diluted) | 0.72 | 3.33 | 3.99 | 3.59 | 5.31 |
EPS Growth | -78.38% | -16.54% | 11.14% | -32.39% | -37.68% |
Free Cash Flow | - | 764 | 548 | 662 | 2,266 |
Free Cash Flow Per Share | - | 2.95 | 2.14 | 2.59 | 8.91 |
Dividend Per Share | 0.340 | 1.120 | 1.120 | 1.120 | 0.560 |
Dividend Growth | -69.64% | - | - | 100.00% | - |
Gross Margin | 54.09% | 58.02% | 59.84% | 62.92% | 62.33% |
Operating Margin | 20.67% | 23.24% | 22.50% | 27.73% | 30.47% |
Profit Margin | 3.01% | 13.49% | 16.33% | 14.85% | 21.43% |
Free Cash Flow Margin | - | 11.93% | 8.75% | 10.72% | 35.95% |
EBITDA | 1,638 | 1,765 | 1,645 | 1,924 | 2,116 |
EBITDA Margin | 26.36% | 27.57% | 26.27% | 31.16% | 33.57% |
D&A For EBITDA | 353.33 | 277 | 236 | 212 | 195 |
EBIT | 1,285 | 1,488 | 1,409 | 1,712 | 1,921 |
EBIT Margin | 20.67% | 23.24% | 22.50% | 27.73% | 30.47% |
Effective Tax Rate | 56.00% | - | - | 18.27% | 11.64% |
Advertising Expenses | - | 206 | 209 | 255 | 236 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.